09 Apr
0
This post was originally published on this site
An experimental drug to treat Alzheimer’s disease just failed a late-stage trial. VTV Therapeutics, a small company in North Carolina, was developing an Alzheimer’s drug azeliragon to inhibit the RAGE receptor, ideally to help people with mild Alzheimer’s delay cognitive decline.
More »